What is the IPA stock price prediction for next 2 weeks?

According to our price prediction algorithm,ImmunoPrecise Antibodies Ltd. (IPA) price will be around $1.52 in the next 2 weeks. This means it will decrease by -6.333333333333334 from the last closing price. This prediction may vary from other time period filters for IPA stock.

What can be the highest Possible price of IPA stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, IPA can achieve the highest price of $1.69 which is 4.169752673592532 higher than last closing price. This prediction may vary from other time period filters for IPA stock.

What can be the lowest Possible price of IPA stock in next 2 weeks?

As per the forecast and algorithmic analysis, IPA stock price can be as low as $1.38 which is -14.994069825887005 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for IPA stock.

Will IPA stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that IPA stock will lose-6.333333333333334 in the next 2 weeks. This prediction may vary from other time period filters for IPA stock.

What is IPA stock last closing price?

Last closing price of IPA stock was $1.57.

What is IPA stock price prediction?

IPA stock price prediction means predicting the future closing prices of IPA stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of IPA stock in a certain time period.

How we predict IPA stock future prices?

If you are searching for IPA stock forecast, analysis or price prediction, then you might be wondering what ImmunoPrecise Antibodies Ltd. (IPA) will do in the future. Our IPA price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This IPA price prediction will likely answer most of your questions.

How frequent we update IPA stock predictions?

We are updating the forecasts for the IPA stock on daily basis.

Is using ML forecasting for IPA stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for IPA stock same for all the time periods?

No, the prediction for IPA stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

ImmunoPrecise Antibodies Ltd. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$1.570%Since 2 Weeks

Predicted Price$1.52-6.33%For 2 Weeks

Upper Predicted Price$1.694.17%For 2 Weeks

Lower Predicted Price$1.38-14.99%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of IPA will decline by -6.33% over the next 2 Weeks and hit $1.52 by Tuesday, November 4, 2025. In that time frame, IPA's share price is expected to range between $1.38 and $1.69.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Nov 4, 2025	1.40	1.56	1.72
Nov 3, 2025	1.42	1.58	1.74
Oct 31, 2025	1.46	1.61	1.77
Oct 30, 2025	1.52	1.67	1.84
Oct 29, 2025	1.44	1.62	1.77
Oct 28, 2025	1.44	1.60	1.78
Oct 27, 2025	1.46	1.62	1.79
Oct 24, 2025	1.49	1.66	1.81
Oct 23, 2025	1.55	1.72	1.88
Oct 22, 2025	1.50	1.66	1.83

IPA shares rose +2.53% in Monday, October 20, 2025's trading session, rising from a previous close of $1.58 to move at $1.62. The stock demonstrated notable intraday movement (see IPA's key stats for a full breakdown), fluctuating between $1.56 and $1.65, a +5.77% trading range. While recent weeks have seen some volatility, IPA has managed to secure a -13.37% drop over the past 2 weeks. The upward price movement was accompanied by decreased trading volume, with approximately 44.85K shares changing hands, 311.41K fewer than the previous session. This amounted to $72.66K in total market activity.

Will IPA Continue Its Upward Trend?

According to analyst ratings and projections for IPA, ImmunoPrecise Antibodies Ltd. shares are anticipated to increase by +5.90%, potentially reaching $1.72 per share by November 4, 2025. Short-term technical indicators currently suggest a neutral sentiment for IPA. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 13 positive trading days within the past 30 sessions. Based on the IPA stock forecast, now is a good time to buy IPA stock because its current trading price is +3.96% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on IPA covering social and institutional perspectives.

IPA Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into IPA's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 48.90% to 49.79%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 50.62%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 51.87%, maintains a neutral outlook for the long term. Insights into IPA's shareholder base show how institutional investors are positioning themselves during these momentum shifts

ImmunoPrecise Antibodies Short-Term Forecasts

IPA Forecast For Next 5 Days

Our algorithm anticipates ImmunoPrecise Antibodies (IPA) stock could hit $1.39 by Nov 14, 2025. This represents a -14.42% fall from today's price, following a -24.73% change over the past five days.

IPA Forecast For Next 30 Days

Based on analysis of market trends, the outlook for ImmunoPrecise Antibodies Ltd. (IPA) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $1.53, which would mean a -5.56% decrease from the current price of $1.62. Projections for this period range from a high of $2.11 to a low of $1.03.

IPA Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for ImmunoPrecise Antibodies's price over the next three months point to a rise. IPA stock is expected to peak at $19.07 on Jan 19, 2026 before potentially dipping to $13.94 on Mar 18, 2026. On average, IPA is likely to trade around $16.54 in the coming 90 days.

ImmunoPrecise Antibodies Stock Forecast 2025

Based on our predictive models, ImmunoPrecise Antibodies (IPA) is expected to trade between $12.32 and $15.80 throughout 2025. This would result in an average price of $14.28, potentially offering investors a +781.48% return from current levels.

ImmunoPrecise Antibodies Ltd. Monthly Forecast 2025–2026

November 2025

According to our latest forecast models, ImmunoPrecise Antibodies Ltd. (IPA) is positioned to show a strong performance in November 2025. The price is predicted to move between $12.32 and $14.14, settling at an average of $13.14. This could translate to a +711.11% gain.

December 2025

Based on current market signals, ImmunoPrecise Antibodies Ltd. is projected to trend december 2025. We forecast a trading range from $14.59 to $15.80, with a likely average price of $15.02. Investors could expect a potential return of +827.16%.

January 2026

Our predictive algorithms indicate ImmunoPrecise Antibodies Ltd. stock may see a shift in January 2026. The expected range spans $14.75–$19.07, with an average target of $16.87. This represents a positive outlook and a possible gain of +941.36%.

February 2026

Analyzing established trends, ImmunoPrecise Antibodies Ltd. looks set to move in February 2026. Projections place the stock between $15.89 and $18.93, averaging around $17.39. This suggests a +973.46% gain from current levels.

March 2026

Market indicators suggest ImmunoPrecise Antibodies Ltd. could experience notable changes during March 2026. Prices could fluctuate within $13.94 to $18.02, with a midpoint forecast of $15.51. The stock might deliver a +857.41% gain.

April 2026

Forecasting for April 2026, models estimate that ImmunoPrecise Antibodies Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $14.35 and $20.81, averaging $16.85. This signals a positive trajectory with potential returns around +940.12%.

May 2026

According to our latest forecast models, ImmunoPrecise Antibodies Ltd. (IPA) is positioned to show a strong performance in May 2026. The price is predicted to move between $18.05 and $21.99, settling at an average of $19.25. This could translate to a +1,088.27% gain.

June 2026

Based on current market signals, ImmunoPrecise Antibodies Ltd. is projected to trend june 2026. We forecast a trading range from $18.56 to $30.15, with a likely average price of $22.78. Investors could expect a potential return of +1,306.17%.

July 2026

Our predictive algorithms indicate ImmunoPrecise Antibodies Ltd. stock may see a shift in July 2026. The expected range spans $26.84–$31.42, with an average target of $27.56. This represents a positive outlook and a possible gain of +1,601.23%.

August 2026

Analyzing established trends, ImmunoPrecise Antibodies Ltd. looks set to move in August 2026. Projections place the stock between $26.12 and $32.47, averaging around $27.30. This suggests a +1,585.19% gain from current levels.

September 2026

Market indicators suggest ImmunoPrecise Antibodies Ltd. could experience notable changes during September 2026. Prices could fluctuate within $25.58 to $32.78, with a midpoint forecast of $27.09. The stock might deliver a +1,572.22% gain.

October 2026

Forecasting for October 2026, models estimate that ImmunoPrecise Antibodies Ltd. may undergo key fluctuations. If trends hold, the stock might trade between $21.89 and $27.66, averaging $22.77. This signals a positive trajectory with potential returns around +1,305.56%.

IPA's history of dividends and stock splits also plays a role in long-term investor confidence.